CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Open-market sale Director and CEO, Alkermes plc sold 50,000 shares at $13.79 ($689,500)
- 4 Open-market sale Director and CEO, Alkermes plc sold 75,000 shares at $14.36 ($1,077,225)
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 25,000 shares at $13.91 ($347,718)
- 4 Open-market sale Director and CEO, Alkermes plc sold 75,000 shares at an average $14.47 ($1,085,428)
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 25,000 shares at an average $13.54 ($338,506)
- 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 7,770 shares (to pay taxes)
- 4 Exercise or conversion SVP, Corp Dev., Alkermes, Inc. acquired 4,500 shares (option exercise)
- 4 Exercise or conversion SVP, CLO, Alkermes, Inc. acquired 5,250 shares (option exercise)
- 4 Shares withheld for taxes SVP, Alks Inc; CFO ALKS gave up 1,323 shares (to pay taxes)
- 4 Shares withheld for taxes SVP Finance & CAO, Alks Inc. gave up 662 shares (to pay taxes)
- 4 Open-market buy Director bought 6,940 shares at $19.65 ($136,371)
- 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 14,386 shares (to pay taxes)
- 4 Exercise or conversion SVP, Corp Dev., Alkermes, Inc. acquired 5,825 shares (option exercise)
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 2,004 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CLO, Alkermes, Inc. gave up 2,016 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Alks Inc; CFO ALKS gave up 1,712 shares (to pay taxes)
- 4 Shares withheld for taxes SVP Finance & CAO, Alks Inc. gave up 1,391 shares (to pay taxes)
- 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 11,958 shares (to pay taxes)
- 4 Exercise or conversion SVP, Corp Dev., Alkermes, Inc. acquired 6,375 shares (option exercise)
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 1,172 shares (to pay taxes)
Page 21 of 67 · 1,323 filings